A DNA test for celiac disease can detect the HLA risk variants (DQ2/DQ8) that are necessary but not sufficient for developing the condition. Only about 2–5 % of individuals with these genetic variants actually develop celiac disease. Therefore, the test cannot diagnose or predict celiac disease with certainty. A definitive diagnosis requires a medical workup including serological antibody tests (tTG-IgA) and, if indicated, an intestinal biopsy. Under German genetic testing law (GenDG), predictive testing for late-onset or non-actionable conditions is restricted, especially for minors. The MyBody-X test provides only a genetic risk indication and does not replace clinical evaluation. The evidence for the HLA association is strong (human-strong), but the practical utility of the test for an individual is limited. Be cautious of marketing claims that present a DNA test as a 'celiac diagnosis'.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-ea4292aef6f87eef281523cc